To address clinical unmet needs and support
better human health, become one of the top
tier pharmaceutical companies in China.
Agility
Innovation
Be Reslistic
Collaboration
Ownership
About HUILUN
Founded in 2004, Shanghai Huilun Pharmaceutical Co., Ltd. (Huilun Pharma) is a high-tech enterprise dedicating to R&D and technical services in the area of innovative small molecule medicine and generic drugs.
Following clinical value guideline, Huilun Pharma has engaged in R&D in various fields spanning respiratory, cardiovascular, oncology, andrology, gynecology, viral, digestive and nervous system diseases, and has a rich pipeline.
Product Introduction
Technological Innovation
R & D System
Huilun is devoted to the development of both generic to fulfil the unmet clinical needs.
R & D Platform
Preclinical Research Platform
Pharmaceutical Research Platform
Clinical Research Platform
R & D Team
We are proud to have a professional R&D team with deep insights into unmet clinical needs, marketing and industrial development of medicine.
R & D Achievements
Over 40 clinical trial permissions approved by CFDA
Over 20 drugs were applied for the
manufacturing licenses with 10+ approved Over 10 APIs passed review
R & D System
Huilun is devoted to the development of both generic to fulfil the unmet clinical needs.
More
R & D Platform
Preclinical Research Platform <br> Pharmaceutical Research Platform<br> Clinical Research Platform
More
R & D Team
We are proud to have a professional R&D team with deep insights into unmet clinical needs, marketing and industrial development of medicine.
More
R & D Achievements
Over 40 clinical trial permissions approved by CFDA<br> Over 20 drugs were applied for the<br> manufacturing licenses with 10+ approved Over 10 APIs passed review
More
News & Information
2025年07月
25
Invitation for Bids for Screw Freezer Unit Equipment from Shanghai Huilun Hubei Pharmaceutical Co., Ltd
2024年03月
07
醫(yī)藥代表信息備案公示
響應(yīng)《醫(yī)藥代表備案制管理辦法（試行）》的相關(guān)要求，現(xiàn)將上海米蘭平臺醫(yī)藥股份有限公司現(xiàn)有醫(yī)藥代表的詳細(xì)備案信息進(jìn)行公示。
2023年04月
06
米蘭平臺湖北原料藥生產(chǎn)基地項目機電安裝工程（罐區(qū)部分）
